Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease. Zhang P, Mao C, Sun A, Yang Y, et al. Alzheimers Dement 2025;21:e70639.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang P, Mao C, Sun A, Yang Y, et al. Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease. Alzheimers Dement 2025;21:e70639.
PMID: 40898408